PTC Therapeutics
PTCT
PTCT
213 hedge funds and large institutions have $4.46B invested in PTC Therapeutics in 2020 Q4 according to their latest regulatory filings, with 39 funds opening new positions, 66 increasing their positions, 82 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
9% more funds holding
Funds holding: 196 → 213 (+17)
1.62% more ownership
Funds ownership: 105.61% → 107.23% (+1.6%)
20% less repeat investments, than reductions
Existing positions increased: 66 | Existing positions reduced: 82
Holders
213
Holding in Top 10
7
Calls
$10.9M
Puts
$256K
Top Buyers
| 1 | +$59.7M | |
| 2 | +$22.8M | |
| 3 | +$19.6M | |
| 4 |
BlackRock
New York
|
+$17.4M |
| 5 |
RI
RTW Investments
New York
|
+$13.9M |
Top Sellers
| 1 | -$11.9M | |
| 2 | -$10.6M | |
| 3 | -$10.5M | |
| 4 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
-$9.19M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$9.08M |